Related Experiment Video
Updated: Nov 6, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Analysis of single nucleotide polymorphisms between 2019-nCoV genomes and its impact on codon usage
Suruchi Gupta1, Prosenjit Paul2, Ravail Singh1
1CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.
Researchers analyzed 108 SARS-CoV-2 genomes, identifying key mutation hotspots in specific genes. This genetic variability information is crucial for developing effective vaccines and antiviral drugs against the virus.
Area of Science:
- Virology
- Genomics
- Molecular Biology
Background:
- The global spread of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) poses a significant threat to public health.
- Understanding the genetic makeup of SARS-CoV-2 is essential for developing effective countermeasures.
- Previous studies highlight the importance of genetic variability in vaccine and drug design.
Purpose of the Study:
- To identify and characterize genome-wide mutations in SARS-CoV-2.
- To pinpoint hypervariable regions within the SARS-CoV-2 genome.
- To assess the impact of identified mutations on codon and amino acid usage patterns.
Main Methods:
- Whole-genome sequencing of 108 SARS-CoV-2 isolates from diverse global locations.
- Bioinformatic analysis to detect nucleotide polymorphisms and mutations.
- Comparative genomics to identify hypervariable regions in orf1ab, spike, and nucleocapsid genes.
Main Results:
- Identification of several hypervariable regions within the SARS-CoV-2 genome, specifically in the orf1ab, spike, and nucleocapsid genes.
- Detected nucleotide polymorphisms significantly influence codon and amino acid usage patterns.
- Analysis of 108 SARS-CoV-2 genomes provides a global perspective on viral genetic diversity.
Conclusions:
- The identified hypervariable regions and mutation patterns offer critical insights into SARS-CoV-2 evolution.
- Findings contribute valuable data for the ongoing development of 2019-nCoV (now SARS-CoV-2) vaccines.
- Understanding genetic variability is key to designing targeted antiviral therapies and vaccines.
More Related Videos
09:26Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
Published on: June 30, 2023
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Leaky Scanning
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Gene Evolution - Fast or Slow?
In contrast, regions which code...